文献速递乳腺MR

600例单中心MRI引导真空辅助乳腺活检的长期结果

Long-term MRI-guided vacuum-assisted breast biopsy results of 600 single-center procedures.
PubMed 文献 · Eur Radiol · 2021-01-18

该单中心回顾性研究评估了1999年9月至2017年3月间600例MRI引导真空辅助乳腺活检(VABB)的技术表现及良性组织学活检的长期结局。技术成功率为99.3%,检出B5病变27.67%、B3病变9.82%、B4病变0.17%;362例良性MRI-VABB平均随访7.6年,仅1例(0.3%)为假阴性。作者认为MRI引导VABB准确度高、长期假阴性率极低,短期随访MRI对每例良性MRI-VABB的价值可能受到质疑。

要点

  • MRI引导VABB技术成功率高(99.3%),可检出较多临床相关病变(B5 27.67%、B3 9.82%、B4 0.17%)。
  • 良性MRI-VABB长期随访(平均7.6年)假阴性率仅0.3%(1/362)。
  • 短期随访MRI未提高检出率,对每例良性MRI-VABB常规行短期随访MRI的价值可能受到质疑。

核心结论

  • MRI引导VABB准确度高,长期随访假阴性率极低(0.3%)。
  • 对每例MRI引导VABB后常规行短期随访MRI的价值可能受到质疑。

研究设计与样本

  • 单中心回顾性研究,评估1999年9月至2017年3月间600例MRI引导VABB操作。
  • 共558名女性,平均年龄51.8岁(范围18-82岁)。
  • 收集患者人口学、MRI-VABB组织病理学诊断及病变基本特征(大小、位置)。
  • 将比利时癌症登记处数据与本中心数据库交叉比对,以识别良性MRI-VABB后随时间发生恶性病变的患者。

诊断标准与关键数值

  • 技术成功率为99.3%。
  • 组织学结果:B5病变27.67%,B3病变9.82%,B4病变0.17%。
  • 362例良性MRI引导VABB中,平均随访7.6年(范围0.8-18.3年),仅1例(0.3%)活检在随访期间为假阴性病变。
  • 短期随访MRI未提高检出率。

临床应用与阅片要点

  • MRI引导VABB后良性组织学结果者长期假阴性率极低(0.3%),短期随访MRI未提高检出率,作者对每例常规短期随访MRI的价值提出质疑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The objective of this study is to report on the performance of the MRI-guided VABB in our center and to look at the long-term outcome of biopsies with benign histology over a period of 19 years.

METHODS: In a single-center retrospective review study, data of 600 VABB procedures performed between September 1999 and March 2017 were evaluated. We collected patient demographics, histopathological diagnosis at MRI-VABB, and basic lesion characteristics (size, location). Data from the Belgian Cancer Registry was cross-referenced with our database to find out which patients with benign MRI-VABB results developed a malignant lesion over time.

RESULTS: These 600 VABB procedures were performed in 558 women with a mean patient age of 51.8 years (range 18-82 years). Our technical success rate was 99.3%. We found 27.67% B5 lesions, 9.82% B3 lesions, and 0.17% B4 lesions. Of 362 benign MRI-guided VABBs, follow-up data was available for a mean follow-up period of 7.6 years (0.8-18.3). Only one (0.3%) biopsy was a false negative lesion after MRI-guided VABB during follow-up. Short-term FU-MRI provided no increase in detection rate.

CONCLUSION: The accuracy of MRI-guided VABB is high with a very low false negative rate of 0.3% on long-term follow-up. The value of short-term FU-MRI for every case after MRI-guided VABB may be questioned.

KEY POINTS: • MRI-guided vacuum-assisted breast biopsies yield a large portion of clinically relevant lesions (9.82% B3, 0.17% B4, and 27.67% B5 lesions). • The false negative biopsy rate of MRI-guided VABB in this study with a mean follow-up time of 7.6 years was only 0.3%. • Performing a short-term follow-up MRI after a benign MRI-guided VABB concordant to the MRI appearance may be questioned.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lambert J, Steelandt T, Heywang-Köbrunner SH, et al. Long-term MRI-guided vacuum-assisted breast biopsy results of 600 single-center procedures. Eur Radiol. 2021. PMID: 33459860. doi:10.1007/s00330-020-07392-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。